Kevin Charles Gorman, a director at Neurocrine Biosciences Inc. (NASDAQ:NBIX), sold a total of 5,844 shares of the company's common stock on February 13, 2025, according to a recent SEC filing. The ...

ORIC Pharmaceuticals (NASDAQ:ORIC – Get Free Report)‘s stock had its “buy” rating reaffirmed by analysts at Guggenheim in a research report issued to clients and investors on Monday,Benzinga reports.

Highlights,Guggenheim raised Tapestry's target price from $70 to $90, signaling increased market confidence.,The company ...

An "unsinkable" ship can still sink. Read on for more facts about what happened on the 'Titanic,' from its famous passengers ...

In an excerpt from this volume of essays, Guy Nordenson explores the traces of history left behind by different construction ...

Let us then get serious about settlements and colonization. I would invite those that want to participate in this project or ...

Confluent (NASDAQ:CFLT – Free Report) had its price objective hoisted by Guggenheim from $32.00 to $35.00 in a research note released on Friday morning,Benzinga reports. Guggenheim currently has a buy ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

In 1662 Charles married Portuguese infanta Catherine of Braganza, daughter of King John IV (she is buried in Portugal). They had no children but Charles had 13 children by various mistresses. Charles ...

Never before, or since, has a king met such an untimely end like Charles I. He was proclaimed king in 1625 upon his father’s death and spent the entirety of his reign in conflict with his parliament.

King Charles III went to Auschwitz in January to mark 80 years since the Nazi concentration camp's liberation. The visit followed a tour of Australia, in October, which reignited the debate about ...